SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Syschem (India) informs about outcome of board meeting

19 Jan 2019 Evaluate

Pursuant to Regulation 30 of SEBI Listing Obligations and Disclosure Requirements) Regulations, 2015, Syschem (India) has informed that the Board in its meeting held on 18th January, 2019 have approved change in the designation of Ranjan Jain (DIN 00635274), Chairman cum Managing Director to Wholetime Director; change in the designation of Suninder Veer Singh (DIN 00635274), Joint Managing Director to Chairman cum Managing Director; postponed the conversion of Convertible Equity Warrants into Equity Shares issued on preferential basis; and Amarjeet Kaur, Company Secretary will act as Company Secretary cum Compliance Officer of the company.

The above information is a part of company’s filings submitted to BSE.

Syschem (India) Share Price

52.87 0.74 (1.42%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×